Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.23.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 111 $ 112
Restricted cash 111 111
Deferred course expenses 200 163
Prepaid expenses and other current assets 347 342
Inventory 1 1
Discontinued operations current assets
Total current assets 770 729
Property and equipment, net
Right-of-use assets 96 113
Other assets 6 6
Discontinued operations-other assets 32 32
Total assets 904 880
Current liabilities:    
Accounts payable 2,682 2,577
Royalties payable 110 110
Accrued course expenses 240 237
Accrued salaries, wages and benefits 308 195
Operating lease liability, current portion 63 67
Other accrued expenses 3,473 2,940
Deferred revenue 3,861 3,470
Short-term related party debt, net of unamortized debt discount of $133 3,260 2,429
Current portion of long term debt, net of unamortized debt discount of $0 1,001 1,184
Discontinued operations-current liabilities 9,442 9,243
Total current liabilities 24,440 22,452
Long-term debt, net of current portion and net of unamortized debt discount 558 558
Deferred tax liability, net 796 796
Other long term liabilities
Operating lease liability, net of current portion 32 46
Total liabilities 25,827 23,852
Stockholders’ deficit:    
Preferred stock, $0.0001 par value, 20,000,000 shares authorized, none issued
Common stock, $0.0001 par value; 200,000,000 authorized; 38,882,697 and 38,182,697 shares issued and outstanding as of March 31, 2023 and December 31, 2022 3 3
Additional paid-in capital 13,221 13,217
Cumulative foreign currency translation adjustment 617 1,593
Accumulated deficit (38,573) (37,695)
Non Controlling Interest (191) (91)
Total stockholders’ deficit (24,923) (22,973)
Total liabilities and stockholders’ deficit $ 904 $ 880